Patent Yard Sign in
Canadian application, no grantCanada

Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound

CA 2263077 A1 · Owner: Whittemore, Marilyn S. · Inventors: Whittemore, Marilyn S.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method for increasing the effectiveness of an anti-fungal compound is described. In the method, an anti-fungal compound and an N-alkyl heterocyclic compound or a salt thereof are administered to a mammal in a combined amount effective to treat a fungal infection. The N-alkyl heterocyclic compound or salt thereof is present in an amount effective to potentiate or increase the anti-fungal activity of the anti-fungal compound. The N-alkyl heterocyclic compound has formula (I). The variable "n" ranges from 5 to 17 and the , heterocyclic ring defined by formula (a) is a substituted or unsubstituted ring having four to eight members. A pharmaceutical composition is described where the …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 8, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 8, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 8, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 8, 1997
GrantedNo grant recorded
Term endedAugust 8, 2017
Patent numberCA 2263077 A1
Classification (IPC)A61K31/53 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedAug 8, 1997Term endedAug 8, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.